Table 7.
Clinical trials on the anticoagulation effects of factor XI inhibitors in dialysis patients
| Identifier | Drugs | Types | Phases | Status |
|---|---|---|---|---|
| NCT03358030 | ISIS 416858 | FXI antisense oligonucleotide | Phase 2 | Completed |
| NCT04534114 | BAY2976217 | FXI antisense oligonucleotide | Phase 2 | Completed |
| NCT04523220 | BAY1213790 (osocimab) | Monoclonal antibody to FXIa | Phase 2 | Completed |
FXI, factor XI; FXIa, activated factor XI.